Sada A - Search Results

1

Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors.

Chen Y, Yamamoto T, Takahashi Y, Moro T, Tajima T, Sakaguchi Y, Sakata N, Yokoyama A, Hijioka S, Sada A, Tabata Y, Ohki R. Chen Y, et al. Among authors: sada a. Cell Death Dis. 2023 Sep 7;14(9):597. doi: 10.1038/s41419-023-06123-1. Cell Death Dis. 2023. PMID: 37679316 Free PMC article.

2

PHLDA3 Is an Important Downstream Mediator of p53 in Squamous Cell Carcinogenesis.

Saito M, Sada A, Fukuyo M, Aoki K, Okumura K, Tabata Y, Chen Y, Kaneda A, Wakabayashi Y, Ohki R. Saito M, et al. Among authors: sada a. J Invest Dermatol. 2022 Apr;142(4):1040-1049.e8. doi: 10.1016/j.jid.2021.09.007. Epub 2021 Sep 27. J Invest Dermatol. 2022. PMID: 34592332 Free article.

3

Elaboration of Non-naturally Occurring Helical Tripeptides as p53-MDM2/MDMX Interaction Inhibitors.

Su A, Tabata Y, Aoki K, Sada A, Ohki R, Nagatoishi S, Tsumoto K, Wang S, Otani Y, Ohwada T. Su A, et al. Among authors: sada a. Chem Pharm Bull (Tokyo). 2021 Jul 1;69(7):681-692. doi: 10.1248/cpb.c21-00238. Epub 2021 Apr 29. Chem Pharm Bull (Tokyo). 2021. PMID: 33952867 Free article.

4

PHLDA1, another PHLDA family protein that inhibits Akt.

Chen Y, Takikawa M, Tsutsumi S, Yamaguchi Y, Okabe A, Shimada M, Kawase T, Sada A, Ezawa I, Takano Y, Nagata K, Suzuki Y, Semba K, Aburatani H, Ohki R. Chen Y, et al. Among authors: sada a. Cancer Sci. 2018 Nov;109(11):3532-3542. doi: 10.1111/cas.13796. Epub 2018 Oct 13. Cancer Sci. 2018. PMID: 30207029 Free PMC article.

5

Non-naturally Occurring Helical Molecules Can Interfere with p53-MDM2 and p53-MDMX Protein-Protein Interactions.

Su A, Wang S, Sada A, Otani Y, Zhai L, Liu X, Sayama M, Ohki R, Ohwada T. Su A, et al. Among authors: sada a. Chem Pharm Bull (Tokyo). 2019;67(10):1139-1143. doi: 10.1248/cpb.c19-00501. Chem Pharm Bull (Tokyo). 2019. PMID: 31582633 Free article.

6

Overall Shape Constraint of Alternating α/β-Hybrid Peptides Containing Bicyclic β-Proline.

Wang S, Otani Y, Zhai L, Su A, Nara M, Kawahata M, Yamaguchi K, Sada A, Ohki R, Ohwada T. Wang S, et al. Among authors: sada a. Org Lett. 2019 Oct 4;21(19):7813-7817. doi: 10.1021/acs.orglett.9b02799. Epub 2019 Sep 13. Org Lett. 2019. PMID: 31518151

7

The effect of hormonal secretion on survival in adrenocortical carcinoma: A multi-center study.

Sada A, Foster TR, Al-Ward R, Sawani S, Charchar H, Pishdad R, Ben-Shlomo A, Dy BM, Lyden ML, Bergsland E, Jasim S, Raj N, Shank JB, Hamidi O, Hamrahian AH, Chambô JL, Srougi V, Fragoso MC, Graham PH, Habra MA, Bancos I, McKenzie TJ. Sada A, et al. Surgery. 2024 Jan;175(1):80-89. doi: 10.1016/j.surg.2023.04.070. Epub 2023 Nov 8. Surgery. 2024. PMID: 37945477

8

Incidence of venous thromboembolism following adrenalectomy: A CESQIP analysis.

Sada A, Habermann EB, Dy BM, Lyden ML, McKenzie TJ, Gruber LM, Foster TR. Sada A, et al. Am J Surg. 2024 Feb;228:226-229. doi: 10.1016/j.amjsurg.2023.10.022. Epub 2023 Oct 5. Am J Surg. 2024. PMID: 37852845

9

Ethanol Ablation for Benign Insulinoma: Intraoperative and Endoscopic Approaches.

Sada A, Ramachandran D, Oberoi M, Habermann EB, Lyden ML, Dy BM, Foster TR, Halfdanarson TR, Levy MJ, Vella A, McKenzie TJ. Sada A, et al. J Surg Res. 2024 Jan;293:663-669. doi: 10.1016/j.jss.2023.08.018. Epub 2023 Oct 13. J Surg Res. 2024. PMID: 37839097

10

Disparities in Parathyroidectomy: Who Receives Appropriate Treatment for Primary Hyperparathyroidism?

Sada A, Hanson KT, Habermann EB, McKenzie TJ, Lyden ML, Foster TR, Clarke BL, Dy BM. Sada A, et al. J Surg Res. 2023 Nov;291:151-157. doi: 10.1016/j.jss.2023.05.014. Epub 2023 Jul 1. J Surg Res. 2023. PMID: 37399633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page